FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer
Author(s) -
Sandra Tavares,
Nalan Liv,
Milena Pasolli,
Mark Opdam,
Max A. K. Rätze,
Manuel Saornil,
Lilian Sluimer,
Rutger C.C. Hengeveld,
Robert van Es,
Erik van Werkhoven,
Harmjan R. Vos,
Holger Rehmann,
Boudewijn Burgering,
Hendrika M. Oosterkamp,
Susanne M.A. Lens,
Judith Klumperman,
Sabine C. Linn,
Patrick W.B. Derksen
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110584
Subject(s) - taxane , endosome , breast cancer , triple negative breast cancer , cancer research , paclitaxel , adjuvant , oncology , cancer , basal (medicine) , receptor tyrosine kinase , medicine , biology , receptor , insulin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom